Cargando…
Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine: Potential Inhibitor of SARS-CoV2
Nowadays, over 200 countries face a wellbeing emergency because of epidemiological disease COVID-19 caused by the SARS-CoV-2 virus. It will cause a very high effect on the world’s economy and the worldwide health sector. The present work is an investigation of the newly synthesized 4-benzyl-1-(2,4,6...
Autores principales: | Nandini Asha, R., Ravindran Durai Nayagam, B., Bhuvanesh, Nattamai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096530/ https://www.ncbi.nlm.nih.gov/pubmed/33975232 http://dx.doi.org/10.1016/j.bioorg.2021.104967 |
Ejemplares similares
-
(E)-N′-(2,4,6-Trimethylbenzylidene)isonicotinohydrazide
por: Naveenkumar, H. S., et al.
Publicado: (2010) -
1-[2,4,6-Trimethyl-3,5-bis(4-oxopiperidin-1-ylmethyl)benzyl]piperidin-4-one
por: Rajesh, K., et al.
Publicado: (2010) -
(E)-4-Chloro-N-(2,4,6-trimethylbenzylidene)aniline
por: Guo, Ying, et al.
Publicado: (2011) -
2,4,6-Trimethyl-3,5-bis[(phenylcarbonothioyl)sulfanylmethyl]benzyl benzenecarbodithioate
por: Kannan, M., et al.
Publicado: (2010) -
N,N′-Bis[(E)-2,4,6-trimethylbenzylidene]ethane-1,2-diamine
por: Yumata, Nonzaliseko, et al.
Publicado: (2011)